Jiangshan Oupai: Appoints Chen Chunjin as Secretary of the Board of Directors
Jiangshan Oupai has appointed Chen Chunjin as the company's board secretary, effective immediately. This move means the company's chairman, Wu Shuigen, will no longer perform the duties of the board secretary. Separately, Huiyu Pharmaceutical's subsidiary, Huiyu Haiyue, has received acceptance from the National Medical Products Administration for its clinical trial application for subcutaneous injection HY07121, a novel biological product designed to treat advanced solid tumors by targeting PD-1, TIGIT, and IL-15/IL-15Rα. AI